Long acting injectable cabotegravir is safe and effective in preventing HIV infection in cisgender women: interim results from HPTN 084

Saved in:
Bibliographic Details
Published in:Journal of the International AIDS Society 2021, Vol.24 (S1), p.8
Main Authors: Moretlwe, S. Delany, Hughes, J, Bock, P, Gurrion, S, Hunidzarira, P, Kalonji, D, Kayange, N, Makhema, J, Mandima, P, Mathew, C, Mokgoro, M, Mpendo, J, Mukwekwerere, P, Mgodi, N, Ntege, P. Nahirya, Nair, G, Nakabiito, C, Biribonwoha, H. Nuwagaba, Panchia, R, Singh, N
Format: Report
Language:English
Subjects:
Antiviral agents
Dosage and administration
Drug therapy
HIV infection
Patient outcomes
Prevention
Women patients
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1758-2652
1758-2652
DOI:10.1002/jia2.25659